Personal

Hasnaa Fatehi

Bringing MedTech to market takes more than regulatory approval. Regulatory strategy, reimbursement and commercialization are often treated as separate workstreams, but decisions made in one can have a significant impact on the others.

From Approval to Adoption: Regulatory, Reimbursement & Commercialization Strategy for MedTech

 brings together three experienced industry leaders to look at the path to market from three connected perspectives.

This session will explore how regulatory decisions influence reimbursement and market access, how reimbursement strategy shapes the commercial model, and how to connect all three earlier to avoid costly missteps and build a stronger path from product development to market adoption.